Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

LD-2 disclosure · 4th Quarter - Report (No Activity)

TRANSPHORM INC

via K&L GATES, LLP

4th Quarter (Oct 1 - Dec 31) · 2023Posted Jan 18, 2024Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: TRANSPHORM INC
Location: * Undetermined

Registrant

Firm: K&L GATES, LLP
Description: Law firm
Location: Washington, District of Columbia, United States of America

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

TRANSPHORM INC — Lobbying — Receipts Report